These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 7893114
1. [Brachytherapy in prostatic adenocarcinoma]. Haie-Meder C, Court B, Perrin JL, Wibault P, Lartigau E, Gerbaulet A. Ann Urol (Paris); 1994; 28(6-7):295-301. PubMed ID: 7893114 [Abstract] [Full Text] [Related]
2. [Results of interstitial radiotherapy using I-125 seeds in the treatment of prostatic cancer]. Rohloff R, Tauber R, Schätzl M, Wendt T, Willich N. Strahlenther Onkol; 1988 Apr; 164(4):195-201. PubMed ID: 3363484 [Abstract] [Full Text] [Related]
3. Experience with interstitial implantation of iodine 125 in the treatment of prostatic carcinoma. Sogani PC, Whitmore WF, Hilaris BS, Batata MA. Scand J Urol Nephrol Suppl; 1980 Apr; 55():205-11. PubMed ID: 6938027 [Abstract] [Full Text] [Related]
4. Curative treatment of carcinoma of the prostate with an association of external irradiation, iridium implant and lymphadenectomy. Gerard JP, De Laroche G, Koonsilin L, Romestaing P, Mornex F. Prog Clin Biol Res; 1987 Apr; 243B():173-6. PubMed ID: 3659017 [No Abstract] [Full Text] [Related]
5. Laparoscopic pelvic lymph node dissection following definitive radiotherapy for carcinoma of the prostate. Lund GO, Winfield HN, Donovan JF, See WA, Loening SA, Williams RD. J Urol; 1997 Feb; 157(2):548-51. PubMed ID: 8996353 [Abstract] [Full Text] [Related]
7. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy. Momma T, Saito S, Toya K, Yorozu A, Dokiya T, Murai M. Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612 [Abstract] [Full Text] [Related]
8. [Determinants of local tumor control in interstitial radiotherapy of prostatic cancer]. Sommerkamp H, Rupprecht M, Bruggmoser G, Wannenmacher M. Urologe A; 1988 Mar; 27(2):117-22. PubMed ID: 3376370 [Abstract] [Full Text] [Related]
9. Simple, accurate, safe, and cost-effective percutaneous transperineal template technique for permanent 125iodine interstitial brachytherapy of prostate cancer. Kumar PP, Good RR, Hussain MB, Bartone FF. Strahlenther Onkol; 1986 Nov; 162(11):713-9. PubMed ID: 3097859 [Abstract] [Full Text] [Related]
10. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view. Nickers P, Thissen B, Jansen N, Deneufbourg JM. Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365 [Abstract] [Full Text] [Related]
11. [Percutaneous, perineal, ultrasound-controlled implantation of 125iodine in prostatic cancer: technics, report of initial experiences and comparison with the retropubic method of implantation]. Riccabona M, Hammer J, Schorn A. Urologe A; 1987 Jan; 26(1):15-21. PubMed ID: 3554696 [Abstract] [Full Text] [Related]
12. [Interstitial radiotherapy of prostatic carcinoma using I-125]. Garofalo FA, Messina S, Lalanne MG, de Santis P, Nanni G, Tomaselli V, Bergamini C. Arch Esp Urol; 1984 Dec; 37 Suppl 2():667-73. PubMed ID: 6537131 [No Abstract] [Full Text] [Related]
13. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Hiratsuka J, Jo Y, Yoshida K, Nagase N, Fujisawa M, Imajo Y. Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):684-90. PubMed ID: 15183471 [Abstract] [Full Text] [Related]
14. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up. Kälkner KM, Wahlgren T, Ryberg M, Cohn-Cedermark G, Castellanos E, Zimmerman R, Nilsson J, Lundell M, Fowler J, Levitt S, Hellström M, Nilsson S. Acta Oncol; 2007 Jul 01; 46(7):909-17. PubMed ID: 17917823 [Abstract] [Full Text] [Related]
15. [Interstitial therapy with 125 iodine seeds of prostatic cancer in elderly men]. Huttner S, Gleichmann R, Scholz R, Antes G. Bildgebung; 1991 Jul 01; 58 Suppl 1():65-6. PubMed ID: 1799853 [Abstract] [Full Text] [Related]
16. Retrospective comparison of radical retropubic prostatectomy and 125iodine brachytherapy for localized prostate cancer. Ramos CG, Carvalhal GF, Smith DS, Mager DE, Catalona WJ. J Urol; 1999 Apr 01; 161(4):1212-5. PubMed ID: 10081871 [Abstract] [Full Text] [Related]
17. [Brachytherapy results in prostatic cancer]. Prada Gómez PJ, Canteli M, Alonso A, Olay L, Alonso R, Reinerio R, Juan G, Fernández J. Arch Esp Urol; 1999 Apr 01; 52(1):32-8; discussion 38-9. PubMed ID: 10101885 [Abstract] [Full Text] [Related]
18. Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy. Potters L, Cha C, Oshinsky G, Venkatraman E, Zelefsky M, Leibel S. Cancer J Sci Am; 1999 Apr 01; 5(5):301-6. PubMed ID: 10526671 [Abstract] [Full Text] [Related]
19. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H. Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838 [Abstract] [Full Text] [Related]
20. Combined I125 seed implant and external irradiation for carcinoma of prostate. Abadir R, Ross G, Edwards FM. J Can Assoc Radiol; 1980 Sep 01; 31(3):190-2. PubMed ID: 7419549 [Abstract] [Full Text] [Related] Page: [Next] [New Search]